Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study

Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study Publisher Pubmed

Sepanlou S¹ ; Najafi F² ; Poustchi H³ ; Parsaeian M⁴ ; Ahmadi A⁵ ; Somi M⁶ ; Moradpour F⁷ ; Alizadehnavaei R⁸ ; Gohari A⁹ ; Zamani B¹⁰ ; Esmaeilinadimi A¹¹ ; Rezaianzadeh A¹² ; Mansourghanaei F¹³ ; Bahramali E¹⁴ Show All Authors

Sepanlou S¹
Najafi F²
Poustchi H³
Parsaeian M⁴
Ahmadi A⁵
Somi M⁶
Moradpour F⁷
Alizadehnavaei R⁸
Gohari A⁹
Zamani B¹⁰
Esmaeilinadimi A¹¹
Rezaianzadeh A¹²
Mansourghanaei F¹³
Bahramali E¹⁴
Ansarimoghaddam A¹⁵
Hamzeh B²
Zanganeh Yousefabadi E¹⁶
Zare Sakhvidi MJ¹⁷
Mohebbi I¹⁸
Fattahi MR¹⁹
Nejatizadeh A²⁰
Marioryad H²¹
Motamedgorji N³
Roozafzai F³
Eghtesad S³
Mohammadi Z³
Shayanrad A³
Sharafkhah M³
Etemadi A²²
Kamangar F²³
Juraschek SP²⁴
Malekzadeh R²⁵

Source: Scientific Reports Published:2022

Abstract

In this cross-sectional population-based study, we used the baseline data of the Prospective Epidemiologic Research Studies in IrAN cohort study collected in Iran from 2014 to 2020. The main outcomes were the prevalence of hypertension and proportion of awareness, treatment, and control based on the 2017 ACC/AHA guideline compared to the seventh report of the Joint National Committee (JNC7). Of the total of 163,770 participants, aged 35–70 years, 55.2% were female. The sex-age standardized prevalence of hypertension was 22.3% (95% CI 20.6, 24.1) based on the JNC7 guideline and 36.5% (31.1, 41.8) based on the ACC/AHA guideline. A total of 24,312 participants [14.1% (10.1, 18.1)] were newly diagnosed based on the ACC/AHA guideline. Compared to adults diagnosed with hypertension based on the JNC7 guideline, the newly diagnosed participants were mainly young literate males who had low levels of risk factors and were free from conventional comorbidities of hypertension. About 30.7% (25.9, 35.4) of them (4.3% of the entire population) were eligible for pharmacologic intervention based on the ACC/AHA guideline. Implementation of the new guideline may impose additional burden on health systems. However, early detection and management of elevated blood pressure may reduce the ultimate burden of hypertension in Iran. © 2022, The Author(s).

Related Docs

View other Related Docs

1. Insight Into Blood Pressure Targets for Universal Coverage of Hypertension Services in Iran: The 2017 Acc/Aha Versus Jnc 8 Hypertension Guidelines, BMC Public Health (2020)

2. Status of Hypertension in Tehran: Potential Impact of the Acc/Aha 2017 and Jnc7 Guidelines, 2012–2015, Scientific Reports (2019)

3. Impact of 2017 Acc/Aha Guideline on Prevalence, Awareness, Treatment, Control, and Determinants of Hypertension: A Population-Based Cross-Sectional Study in Southwest of Iran, Population Health Metrics (2021)

Experts (# of related papers)

View all Related Experts

Hossein Poustchi (6)

Sadaf Ghajarieh Sepanlou (5)

Style	Citing Format
MLA	Sepanlou S, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports, vol. 12, no. 1, 2022, pp. -.
APA	Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, Alizadehnavaei R, Gohari A, Zamani B, Esmaeilinadimi A, Rezaianzadeh A, Mansourghanaei F, Bahramali E, Ansarimoghaddam A, Hamzeh B, Zanganeh Yousefabadi E, Zare Sakhvidi MJ, Mohebbi I, ... Malekzadeh R (2022). Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports, 12(1), -.
Chicago	Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports 12, no. 1 (2022): -.
Harvard	Sepanlou S et al. (2022) 'Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study', Scientific Reports, 12(1), pp. -.
Vancouver	Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, et al.. Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports. 2022;12(1):-.
BibTex	@article{ author = {Sepanlou S and Najafi F and Poustchi H and Parsaeian M and Ahmadi A and Somi M and Moradpour F and Alizadehnavaei R and Gohari A and Zamani B and Esmaeilinadimi A and Rezaianzadeh A and Mansourghanaei F and Bahramali E and Ansarimoghaddam A and Hamzeh B and Zanganeh Yousefabadi E and Zare Sakhvidi MJ and Mohebbi I and Fattahi MR and Nejatizadeh A and Marioryad H and Motamedgorji N and Roozafzai F and Eghtesad S and Mohammadi Z and Shayanrad A and Sharafkhah M and Etemadi A and Kamangar F and Juraschek SP and Malekzadeh R}, title = {Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Sepanlou S AU - Najafi F AU - Poustchi H AU - Parsaeian M AU - Ahmadi A AU - Somi M AU - Moradpour F AU - Alizadehnavaei R AU - Gohari A AU - Zamani B AU - Esmaeilinadimi A AU - Rezaianzadeh A AU - Mansourghanaei F AU - Bahramali E AU - Ansarimoghaddam A AU - Hamzeh B AU - Zanganeh Yousefabadi E AU - Zare Sakhvidi MJ AU - Mohebbi I AU - Fattahi MR AU - Nejatizadeh A AU - Marioryad H AU - Motamedgorji N AU - Roozafzai F AU - Eghtesad S AU - Mohammadi Z AU - Shayanrad A AU - Sharafkhah M AU - Etemadi A AU - Kamangar F AU - Juraschek SP AU - Malekzadeh R TI - Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study JO - Scientific Reports VL - 12 IS - 1 SP - EP - PY - 2022 ER -

Style

Citing Format

MLA

Sepanlou S, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports, vol. 12, no. 1, 2022, pp. -.

APA

Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, Alizadehnavaei R, Gohari A, Zamani B, Esmaeilinadimi A, Rezaianzadeh A, Mansourghanaei F, Bahramali E, Ansarimoghaddam A, Hamzeh B, Zanganeh Yousefabadi E, Zare Sakhvidi MJ, Mohebbi I, ... Malekzadeh R (2022). Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports, 12(1), -.

Chicago

Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, Moradpour F, et al.. "Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study." Scientific Reports 12, no. 1 (2022): -.

Harvard

Sepanlou S et al. (2022) 'Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study', Scientific Reports, 12(1), pp. -.

Vancouver

Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, et al.. Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study. Scientific Reports. 2022;12(1):-.

BibTex

@article{ author = {Sepanlou S and Najafi F and Poustchi H and Parsaeian M and Ahmadi A and Somi M and Moradpour F and Alizadehnavaei R and Gohari A and Zamani B and Esmaeilinadimi A and Rezaianzadeh A and Mansourghanaei F and Bahramali E and Ansarimoghaddam A and Hamzeh B and Zanganeh Yousefabadi E and Zare Sakhvidi MJ and Mohebbi I and Fattahi MR and Nejatizadeh A and Marioryad H and Motamedgorji N and Roozafzai F and Eghtesad S and Mohammadi Z and Shayanrad A and Sharafkhah M and Etemadi A and Kamangar F and Juraschek SP and Malekzadeh R}, title = {Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} }

RIS

TY - JOUR
AU - Sepanlou S
AU - Najafi F
AU - Poustchi H
AU - Parsaeian M
AU - Ahmadi A
AU - Somi M
AU - Moradpour F
AU - Alizadehnavaei R
AU - Gohari A
AU - Zamani B
AU - Esmaeilinadimi A
AU - Rezaianzadeh A
AU - Mansourghanaei F
AU - Bahramali E
AU - Ansarimoghaddam A
AU - Hamzeh B
AU - Zanganeh Yousefabadi E
AU - Zare Sakhvidi MJ
AU - Mohebbi I
AU - Fattahi MR
AU - Nejatizadeh A
AU - Marioryad H
AU - Motamedgorji N
AU - Roozafzai F
AU - Eghtesad S
AU - Mohammadi Z
AU - Shayanrad A
AU - Sharafkhah M
AU - Etemadi A
AU - Kamangar F
AU - Juraschek SP
AU - Malekzadeh R
TI - Prevalence, Awareness, Treatment, and Control of Hypertension Based on Acc/Aha Versus Jnc7 Guidelines in the Persian Cohort Study
JO - Scientific Reports
VL - 12
IS - 1
SP -
EP -
PY - 2022
ER -

Science Communicator Platform

Authors

Abstract